CBD Retail in 2026: Why Self-Serve Kiosks Are Outperforming Brick-and-Mortar
Self-serve retail has moved well beyond snacks and beverages, and hemp-derived CBD is a natural fit for the format. Because the 2018 Farm Bill legalized hemp containing no more than 0.3% delta-9 THC, compliant CBD products can be sold at general retail rather than being confined to licensed cannabis dispensaries—opening the door to unattended kiosks in high-traffic locations. Across our own network, automated units consistently show faster checkout, strong customer satisfaction, and encouraging repeat-purchase behavior compared with staffed counters.
The efficiency comes from removing friction: a kiosk is always open, never out of a knowledgeable associate, and can surface a product's Certificate of Analysis on screen at the moment of purchase. That transparency matters because the FDA has not approved CBD as a dietary supplement or food additive and does not certify over-the-counter CBD products, so third-party lab results are the main assurance a shopper has. Kiosks also enforce age gating and inventory tracking with more consistency than a busy retail floor.
None of this changes what CBD is or is not. These products are not FDA-approved to treat, cure, or prevent disease, and nothing sold from a kiosk should be read as medical advice. The retail shift is about convenience, compliance, and transparency—giving customers a fast, verifiable way to buy legal hemp products while still encouraging them to consult a healthcare provider about their own use.
Sources: Agriculture Improvement Act of 2018; U.S. Food & Drug Administration
